Propel Bio Management, LLC Q3 2025 Filing
Filed November 12, 2025
Portfolio Value
$99.9B
Holdings
16
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PAGPPLAINS GP HOLDINGS LP-CL | 1,272,360 | $23.2B | 23.23% | |
| 2 | SP4PACHIEVE LIFE SCIENCES INC | 3,786,425 | $11.9B | 11.94% | |
| 3 | AKROAKERO THERAPEUTICS INC | 228,884 | $10.9B | 10.88% | |
| 4 | MISTMILESTONE PHARMACEUTICALS | 5,124,890 | $10.2B | 10.26% | |
| 5 | APLTAPPLIED THERAPEUTICS INC | 11,285,420 | $6.8B | 6.83% | |
| 6 | PHATPHATHOM PHARMACEUTICALS I | 552,927 | $6.5B | 6.51% | |
| 7 | ABEOABEONA THERAPEUTICS INC | 974,022 | $5.1B | 5.15% | |
| 8 | DCTHDELCATH SYSTEMS INC | 438,509 | $4.7B | 4.72% | |
| 9 | TCE2CELLDEX THERAPEUTICS INC | 155,000 | $4.0B | 4.01% | |
| 10 | TCRXTSCAN THERAPEUTICS INC | 1,932,304 | $3.5B | 3.52% | |
| 11 | CMPSCOMPASS PATHWAYS PLC | 510,000 | $2.9B | 2.93% | |
| 12 | NKTRNEKTAR THERAPEUTICS | 49,000 | $2.8B | 2.79% | |
| 13 | JSPRJASPER THERAPEUTICS INC | 1,028,806 | $2.4B | 2.45% | |
| 14 | ZVRAZEVRA THERAPEUTICS INC | 231,874 | $2.2B | 2.21% | |
| 15 | VRDNVIRIDIAN THERAPEUTICS INC | 90,000 | $1.9B | 1.94% | |
| 16 | LONAATHIRA PHARMA INC | 149,279 | $618.0M | 0.62% |